What Next: TBD | Tech, power, and the future
Technology
The diabetes medication Ozempic has exploded in popularity, particularly amongst those in Hollywood looking to lose a few extra pounds. But a silver bullet for weight loss leads to a number of questions: Is “buying weight loss” via injection somehow worse than diet and exercise? Are so many people buying and using this drug that people who need it for its intended purpose are missing out? What happened to body positivity?
Guest: Matthew Schneier, feature writer for New York Magazine.
Host: Lizzie O’Leary
If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Why Flying Is So Bad Now
Wait, TikTok Has a Sister App?
Seeking Asylum Via App
When A.I. Denies Your Health Care
Tesla’s Full Self-Driving Woes
The Case Against TikTok
When A.I. Steals Your Voice
Where Is Silicon Valley Going to Bank Now?
Would You Let A.I. Date For You?
When Meta Tells Law Enforcement About Your Abortion
What Would Convince a Lab Leak Skeptic?
Is a 25-Year-Old’s Brain Mature?
Why A.I. Says the Darndest Things
The Baby-Sleep Industrial Complex
What Made the Balloon Drama Pop Off?
Contraband Tech Behind Bars
Why Ban TikTok?
Did a Twentysomething Con America’s Biggest Bank?
How COVID Changes Our Immune Systems
Create your
podcast in
minutes
It is Free
Slow Burn
Slate Debates
What Next | Daily News and Analysis
Decoder Ring
Amicus With Dahlia Lithwick | Law, justice, and the courts